LEON O. MOULDER JR - 11 Sep 2023 Form 4 Insider Report for Dianthus Therapeutics, Inc. /DE/ (DNTH)

Role
Director
Signature
/s/ Adam Veness, as attorney-in-fact for Leon O. Moulder Jr.
Issuer symbol
DNTH
Transactions as of
11 Sep 2023
Transactions value $
$0
Form type
4
Filing time
13 Sep 2023, 22:13:10 UTC
Previous filing
30 Jun 2023
Next filing
24 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNTH Stock Option (Right to Buy) Award $0 +6.5K $0.00 6.5K 11 Sep 2023 Common Stock 6.5K $11.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 6,500 shares of the Issuer's common stock, which will vest in full on the date that is the earlier of (i) the Issuer's 2024 Annual Meeting of Stockholders and (ii) September 11, 2024, subject to the Reporting Person's continued service to the Issuer.